In this episode, Lisa Jones interviews Elizabeth L. Wright, MS, RD, CSP, LDN, FAND, CLC, and Michele Shuker, MS, RD, CSP, LDN, on the impact of nutrition on rare disease, including eosinophilic disorders...
In this podcast, Jelena Pavlovic, MD, PhD, discusses the implications of her team's research presented in the session "Ubrogepant Was Safe and Well Tolerated in the Acute Treatment of Perimenstrual...
She talks about treating sleep conditions in children and adults with autism. Because 1 out of every 59 children has autism, practitioners will soon see more adults with autism and sleep disorders.
He discusses the changes that need to be made in the research community to encompass a larger representative cohort, how current events will shape the future of neurology, and how the American Neurological...
In this episode, Ryan Maddox, PhD, discusses his team's study on the incidence of prion disease in the United States from 2003 to 2015, and also examines the topic in the context of his prior research in...
In this podcast, Dr Shah discusses the imaging and treatment modalities he and his colleagues reviewed in their recent article, "Advanced MRI techniques for transcranial high intensity focused ultrasound...
In this podcast, Susan Hutchinson, MD, discusses the implications for her team's research presented in the session "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults with Migraine and...
In this podcast, Dr Garg discusses the findings from her recent study on neurological diagnostic testing among elderly adult patients with acute altered mental status. This study was featured in the 2020...
In this podcast, Shane Liddelow, PhD, from NYU Langone Health, discusses his latest research on astrocytes—a topic he also spoke about at the Alzheimer's Association International Conference 2019.
Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their...
